Isotretinoin and antidepressant pharmacotherapy: A prescription sequence symmetry analysis

Healy, 1994, Acne vulgaris, BMJ, 308, 831, 10.1136/bmj.308.6932.831

Rademaker, 1989, Acne in schoolchildren, BMJ, 298, 1217, 10.1136/bmj.298.6682.1217

Krowchuk, 1991, The psychosocial effects of acne on adolescents, Pediatr Dermatol, 8, 332, 10.1111/j.1525-1470.1991.tb00945.x

Gupta, 1998, Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis, Br J Dermatol, 139, 846, 10.1046/j.1365-2133.1998.02511.x

Pearl, 1998, The impact of acne, N Z Med J, 111, 269

Koo, 1991, Psychological aspects of acne, Pediatr Dermatol, 8, 185, 10.1111/j.1525-1470.1991.tb00856.x

Kellett, 1999, The psychological and emotional impact of acne and the effect of treatment with isotretinoin, Br J Dermatol, 140, 273, 10.1046/j.1365-2133.1999.02662.x

Gupta, 1990, Psychiatric aspects of the treatment of mild to moderate facial acne, Int J Dermatol, 29, 719, 10.1111/j.1365-4362.1990.tb03777.x

Rubinow, 1987, Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin, J Am Acad Dermatol, 17, 25, 10.1016/S0190-9622(87)70166-2

Niemeier, 1998, Coping with acne vulgaris, Dermatology, 196, 108, 10.1159/000017842

Mallon, 1999, The quality of life in acne, Br J Dermatol, 140, 672, 10.1046/j.1365-2133.1999.02768.x

Lasek, 1998, Acne vulgaris and the quality of life of adult dermatology patients, Arch Dermatol, 134, 454, 10.1001/archderm.134.4.454

Roaccutane periodic safety update report, Sept 1, 2000–Aug 31, 2001. Nutley (NJ); Hoffmann-LaRoche, Inc; 2001. Submitted to the European Agency for the Evaluation of Medical Products (EMEA)

Burrall BA. Isotretinoin: dosing, safety, and a new formulation. Proceedings of the 59th annual meeting of the American Academy of Dermatology; 2001 March 2-7; Washington DC. Washington: The Academy; 2001

Wysowski, 2001, An analysis of reports of depression and suicide in patients treated with isotretinoin, J Am Acad Dermatol, 45, 515, 10.1067/mjd.2001.117730

Jick, 2000, Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide, Arch Dermatol, 136, 1231, 10.1001/archderm.136.10.1231

Transcripts from FDA Dermatologic and Opthalmic Drug Advisory Committee Meeting Sept 18-19, 2000. Safety issue work-up: review of all spontaneous reports of psychiatric onditions—reporting period: market introduction (1982) through April 30, 1999. May 31, 2000. Nelson Robert C. Available from: http://www.fda.gov/ohrms/dockets/ac/cder00.htm#DermatologicandOphthalmic. Revised April 25, 2001. Accessed September 2001

Transcripts from FDA Dermatologic and Opthalmic Drug Advisory Committee Meeting Sept 18-19, 2000. Clinical review: clinical psychiatric analysis of suicide cases, Douglas Jacobs, MD. Available from: http://www.fda.gov/ohrms/dockets/ac/cder00.htm#Dermatologic and Ophthalmic. Revised April 25, 2001. Accessed September 2001

Neary MP, Klaskala W, McLane J, Ackermann SP. Epidemiological study of adverse events in Accutane users and matched non-users: retrospective analysis of major US health plan claims database. Proceedings of the 17th International Conference on Pharmacoepidemiology; 2001 Aug 23-26; Toronto, Ontario, Canada. Toronto: The Conference; 2001

Rohrback JM, Feldman SR, Krowchuk DP, Felischer AB. Incidence of acne and depressive disorders in isotretinoin users. Proceedings of the 62nd annual meeting of the Society for Investigative Dermatology; 2001 May 9-12; Washington, DC. Washington: The Society; 2001

Petri, 1990, Rapid method for estimating the risk of acutely controversial side effects of prescription drugs, J Clin Epidemiol, 43, 433, 10.1016/0895-4356(90)90131-8

Cher, 2000, Myocardial infarction and acute cholecystitis, Epidemiology, 11, 446, 10.1097/00001648-200007000-00014

Hallas, 1996, Evidence of depression provoked by cardiovascular medication, Epidemiology, 7, 478, 10.1097/00001648-199609000-00004

Bytzer, 2000, Drug-induced symptoms of functional dyspepsia and nausea; a symmetry analysis of one million prescriptions, Aliment Pharmacol Ther, 14, 1479, 10.1046/j.1365-2036.2000.00862.x

Lindberg, 1998, Cholesterol-lowering drugs and antidepressants, Pharmacoepidemiol Drug Safety, 7, 399, 10.1002/(SICI)1099-1557(199811/12)7:6<399::AID-PDS385>3.0.CO;2-C

National Institute of Mental Health. Depression research at the National Institute of Mental Health. Available from http://www.nimh.nih.gov/publicat/depresfact.htm. Updated April 13, 1999. Accessed October 2001

Petri, 1988, Prescription sequence analysis, Stat Med, 7, 1171, 10.1002/sim.4780071110

Hallas, 1997, The waiting time distribution as a graphical approach to epidemiologic measures of drug utilization, Epidemiology, 8, 666, 10.1097/00001648-199711000-00013